Phase Ii Study Of Paclitaxel Given Once Per Week Along With Trastuzumab And Pertuzumab In Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer (Vol 33, Pg 442, 2015)
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined